Pfizer and BioNTech co-develop potential Coronavirus (COVID-19)
On Mar. 17, 2020, Pfizer and BioNTech SE announced the companies have agreed to a letter of intent…
Regeneron announced important advances in novel COVID-19 antibody program
On Mar. 17, 2020, Regeneron announced that its scientists had isolated hundreds of virus-neutralizing, fully human antibodies from…
Todos Medical announced Coronavirus Nucleic Acid Buccal Testing Kit distribution agreement with 3D BioMed
On Mar. 17, 2020, Todos Medical announced a non-exclusive distribution agreement with 3D Biomedicine Science & Technology, a…
UMN Institute scientist links ancient virus to cancer risk
On Mar. 16, 2020, the Hormel Institute, University of Minnesota announced published research concerning remnants of ancient viruses…
NIH clinical trial of investigational vaccine for COVID-19 began in Seattle
On Mar. 16, 2020, the National Institutes of Health (NIH announced that a Phase 1 clinical trial evaluating…
Research on brain structure highlighted cells linked to Alzheimer’s and autism
On Mar. 16, 2020, new insights into the architecture of the brain were revealed by scientists at the…
Aimmune announced first U.S. patients treated with PALFORZIA, the first treatment for peanut allergy
On Mar. 16, 2020, Aimmune Therapeutics announced that the first patients in the U.S. were being treated with…
Moderna announced first participant dosed in NIH-led phase 1 study of mRNA vaccine against novel Coronavirus
On Mar. 16, 2020, Moderna announced that the first participant had been dosed in the Phase 1 study…
Biotechnology | COVID-19 | Diagnostics | FDA
Hologic’s molecular test for the novel Coronavirus, SARS-CoV-2, receives FDA Emergency Use Authorization
On Mar. 16, 2020, Hologic announced the U.S. Food and Drug Administration (FDA) had granted Emergency Use Authorization…
Biotechnology | COVID-19 | Diagnostics | FDA
BD, BioGX announced FDA Emergency Use Authorization submissions for new COVID-19 diagnostics for use in U.S.
On Mar. 16, 2020, BD (Becton, Dickinson and Company) announced the companies had submitted Emergency Use Authorization requests…
OpGen updated on Curetis Now Offering BGI’s CE-IVD rapid test kit for Coronavirus in Europe
On Mar. 16, 2020, OpGen reported an update on the business of Curetis, the other party to the…
Sanofi and Regeneron began global Kevzara (sarilumab) clinical trial program in patients with severe COVID-19
On Mar. 16, 2020, Sanofi and Regeneron Pharma announced they have started a clinical program evaluating Kevzara (sarilumab)…
Meridian Bioscience supports companies in fighting Coronavirus withg zero cost proprietary technology for evaluation
On Mar. 16, 2020, Meridian Bioscience announced today its increased commitment to the global fight against COVID-19 by…
PathGroup launched testing for Coronavirus Disease 2019 (COVID-19)
On Mar. 16, 2020, PathGroup announced it had begun to offer testing for Coronavirus Disease 2019 (COVID-19). This…
COVID-19 | Diagnostics | NIH
NIH Reported First Known Employee with COVID-19 Infection
On Mar. 15, 2020, the National Institutes of Health (NIH) informed its staff that it had its first…
CureVac focuses on development of mRNA-based coronavirus vaccine to protect people worldwide
On Mar. 15, 2020, CureVac announced that internal efforts will be focused on the development of a coronavirus…
Fosun Pharma and BioNTech formed COVID-19 vaccine strategic alliance in China
On Mar. 15, 2020, Fosun Pharma and BioNTech announced a strategic development and commercialization collaboration to advance BioNTech’s…
Ativa to validate rapid point-of-care sepsis diagnostics
On Mar. 14, 2020, Ativa announced it was working with Associate Professor James Fackler from Critical Care Medicine,…
CureVac’s optimized mRNA platform provided positive pre-clinical results at low dose for Coronavirus vaccine candidate
On Mar. 14, 2020, CureVac announced positive pre-clinical results at a low dose for its lead vaccine candidate…
Roche announced FDA Emergency Use Authorization and availablabilityof cobas SARS-CoV-2 detection test
On Mar. 13, 2020, Roche announced the FDA has issued an Emergency Use Authorization for the cobasﾮ SARS-CoV-2…
FDA issued Emergency Use Authorization to Thermo Fisher Scientific for diagnostic test for COVID-19
On Mar. 13, 2020, Thermo Fisher Scientific announced the FDA has issued an emergency use authorization (EUA) for…
Disease | Therapeutics | WHO
National Emergency declared in U.S. for novel Coronavirus disease outbreak
On Mar. 13, 2020, the Federal Government, along with State and local governments, announced preventive and proactive measures…
Long-term analysis showed GM cotton no match for insects in India
On Mar. 13, 2020, Washington University in St. Louis announced the first long-term study of Bt cotton impacts…
Biotechnology | COVID-19 | Diagnostics | Genomics | Medicine | Therapeutics
Large scale COVID-19 testing of general population begun in Iceland
On Mar. 13, 2020, Iceland health authorities and deCode Genetics announced they began comprehensive screening for the virus…
Enanta Pharmaceuticals announced efforts to discover treatment for novel Coronavirus disease
On Mar. 13, 2020, Enanta Pharmaceuticals announced it had initiated a program to discover direct-acting antiviral drug candidates…
Leading veterinary diagnostic company saw no COVID-19 cases in pets early in Pandemic
On Mar. 13, 2020, IDEXX Laboratories announced the company had seen no positive results in pets to date…
Johnson & Johnson collaborated with Beth Israel Deaconess Medical Center to accelerate COVID-19 vaccine development
On Mar. 13, 2020, Johnson & Johnson announced that its Janssen Pharmaceutical Companies have entered a collaboration with…
BioReference Laboratories offers testing for Coronavirus disease 2019 (COVID-19)
On Mar. 13, 2020, BioReference Laboratories, an OPKO company, announced it had begun accepting specimens for testing of…
Luminex provided update on SARS-CoV-2 validation testing efforts
On Mar. 13, 2020, Luminex announced that four independent clinical laboratories had validated laboratory developed tests (LDTs) for…
COVID-19 accelerated the shift from paper forms to digital data in Vietnam
On Mar. 13, 2020, PATH and the Centers for Disease Control and Prevention (CDC) announced a collaboration with…